Skip to main content

Advertisement

Table 1 Association between ZEB1 expression and clinicopathological factors in breast cancer

From: Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy

Variables Number (%) Number (%) p value
ZEB1 negative and weak expression ZEB1 strong expression
Age
 > 50 23 (30.6) 14 (18.7) 0.015
 ≤ 50 13 (17.3) 25 (33.3)
Tumor size (cm)
 > 5 19 (16.8) 23 (30.7) 0.308
 ≤ 5 17 (22.7) 16 (21.3)
ER status
 Positive 25 (33.3) 32 (42.7) 0.202
 Negative 11 (14.7) 7 (9.3)
PR status
 Positive 32 (42.7) 32 (42.7) 0.403
 Negative 4 (5.3) 7 (9.3)
Ki-67 status (%)
 > 30 17 (23.7) 22 (29.3) 0.426
 ≤ 30 19 (25.3) 17 (23.7)
HER2
 Positive 13 (17.3) 15 (20.0) 0.833
 Negative 23 (30.6) 24 (32.0)
Lymph node positive
 > 0 15 (20.0) 23 (30.6) 0.134
 ≤ 0 21 (28.0) 16 (21.3)
Menopausal status
 Premenopausal 23 (30.6) 14 (18.7) 0.015
 Postmenopausal 13 (17.3) 25 (33.3)
  1. Siginificant p values are given in italic (p < 0.05)
  2. The χ2 test was used for comparison between groups